These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15557605)

  • 41. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mycoplasma pulmonis and lymphoma in bioassays in rats.
    Schoeb TR; McConnell EE; Juliana MM; Davis JK; Davidson MK; Lindsey JR
    Vet Pathol; 2009 Sep; 46(5):952-9. PubMed ID: 19430000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro effects of Mycoplasma pulmonis on murine natural killer cell activity.
    Swing SP; Davis JK; Egan ML
    Lab Anim Sci; 1995 Aug; 45(4):352-6. PubMed ID: 7474870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of Mycoplasma pulmonis in laboratory rats and technicians.
    Ferreira JB; Yamaguti M; Marques LM; Oliveira RC; Neto RL; Buzinhani M; Timenetsky J
    Zoonoses Public Health; 2008 Jun; 55(5):229-34. PubMed ID: 18454744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mycoplasma pulmonis 46-kDa trypsin-resistant protein adheres to rat tracheal epithelial cells.
    Beyers TM; Lai WC; Read RW; Pakes SP
    Lab Anim Sci; 1994 Dec; 44(6):573-8. PubMed ID: 7898030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variation in the virulence of strains of Mycoplasma pulmonis related to susceptibility to killing by macrophages in vivo.
    Howard CJ; Taylor G
    J Gen Microbiol; 1979 Oct; 114(2):289-94. PubMed ID: 232125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short-term exposure to nitrogen dioxide enhances susceptibility to murine respiratory mycoplasmosis and decreases intrapulmonary killing of Mycoplasma pulmonis.
    Parker RF; Davis JK; Cassell GH; White H; Dziedzic D; Blalock DK; Thorp RB; Simecka JW
    Am Rev Respir Dis; 1989 Aug; 140(2):502-12. PubMed ID: 2504091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mycoplasma pulmonis and lymphoma.
    Schoeb TR; McConnell EE; Juliana MM; Davis JK; Davidson MK; Lindsey JR
    Environ Mol Mutagen; 2009 Jan; 50(1):1-3; author reply 6-9. PubMed ID: 19107899
    [No Abstract]   [Full Text] [Related]  

  • 49. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Secondary intratracheal infection of mice with Mycoplasma pulmonis generates IgG1 memory B cells.
    Rose FV; Cebra JJ
    Isr J Med Sci; 1987 May; 23(5):490-5. PubMed ID: 3499421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of time of exposure to rat coronavirus and Mycoplasma pulmonis on respiratory tract lesions in the Wistar rat.
    Schunk MK; Percy DH; Rosendal S
    Can J Vet Res; 1995 Jan; 59(1):60-6. PubMed ID: 7704844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune response to Mycoplasma pulmonis in nasal mucosa is modulated by the normal microbiota.
    Henriksson G; Helgeland L; Midtvedt T; Stierna P; Brandtzaeg P
    Am J Respir Cell Mol Biol; 2004 Dec; 31(6):657-62. PubMed ID: 15347559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. General N-and O-Linked Glycosylation of Lipoproteins in Mycoplasmas and Role of Exogenous Oligosaccharide.
    Daubenspeck JM; Jordan DS; Simmons W; Renfrow MB; Dybvig K
    PLoS One; 2015; 10(11):e0143362. PubMed ID: 26599081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunological response of rodents to murine mycoplasmas.
    Cole BC; Golightly-Rowland L; Ward JR; Wiley BB
    Infect Immun; 1970 Oct; 2(4):419-25. PubMed ID: 16557855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sequence analysis of the gliding protein Gli349 in
    Metsugi S; Uenoyama A; Adan-Kubo J; Miyata M; Yura K; Kono H; Go N
    Biophysics (Nagoya-shi); 2005; 1():33-43. PubMed ID: 27857551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plaque-forming factor produced by Mycoplasma pulmonis.
    Gourlay RN; Wyld SG; Taylor-Robinson D
    Nature; 1976 Jan; 259(5539):120-2. PubMed ID: 1246349
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum Resistance of
    Sommer K; Kowald S; Chopra-Dewasthaly R
    Pathogens; 2022 Sep; 11(9):. PubMed ID: 36145468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies Specific to Membrane Proteins Are Effective in Complement-Mediated Killing of Mycoplasma bovis.
    Zhang YK; Li X; Zhao HR; Jiang F; Wang ZH; Wu WX
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31548318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Role of Lipoproteins in Mycoplasma-Mediated Immunomodulation.
    Christodoulides A; Gupta N; Yacoubian V; Maithel N; Parker J; Kelesidis T
    Front Microbiol; 2018; 9():1682. PubMed ID: 30108558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identifying genome-wide immune gene variation underlying infectious disease in wildlife populations - a next generation sequencing approach in the gopher tortoise.
    Elbers JP; Brown MB; Taylor SS
    BMC Genomics; 2018 Jan; 19(1):64. PubMed ID: 29351737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.